Preeclampsia and Chlamydia pneumoniae: Is there a link?

Hypertension in Pregnancy

Volumn 23, Issue 2, 2004, Pages 129-134

  Raynor, B Denise ^a   Bonney, Elizabeth A ^a,b   Jang, Kyung T ^a   Coto, Wendy ^a   Garcia, Meera S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Chlamydia Pneumoniae; Immunology; Preeclampsia; Pregnancy

Indexed keywords

BACTERIUM ANTIBODY; CHLAMYDIA ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MULTIFACTORIAL GENETIC DISORDER; OBESITY; PREECLAMPSIA; RISK FACTOR; SERODIAGNOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; BODY MASS INDEX; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; GEORGIA; HUMANS; MATERNAL WELFARE; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS;

EID: 4143077207     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.1081/PRG-120028284     Document Type: Article

References (21)

1. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179(5):1359-1375.
2. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Llupien PJ, Despres JP. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors in ischemic heart disease. JAMA 1998; 279:155-1961.
3. Sampfer MJ, Krauss RM, Ma J, Blanche PJ, Hol LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276:882-888.
4. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the hordaland homocysteine study. Am J Clin Nutr 2000; 71:962-968.
5. Sattar N, Bedomir A, Berry C, Shepherd J, Greer I, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia. Pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89:403-408.
6. DeWolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975; 123:164-174.
7. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999; 340:115-126.
8. Roberts JM, Hubel CA. Is oxidative stress the link in the two stage model of preeclampsia? Lancet 1999; 345(9181):788-789.
9. Jonsdottir LS, Arngrimsson R, Geirsson R, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74:772-776.
10. Seeley EW. Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. J Clin Endocrinol Metab 1999; 84(6):1858-1861.
11. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxemia of pregnancy. Heart 1997; 77:154-158.
12. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180(1):499-506.
13. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179(1):80-86.
14. Campbell LA, Kuo CC, Grayston JT. Chlamydia pneumoniae and cardiovascular disease. Eur J Inf Dis 1998; 4(4).
15. Wang SP, Grayston JT. Population prevalence antibody to Chlamdyia pneumoniae strain TWAR. In: Bowie WR, Caldwell HO, Jones RP, eds. Chlamydial Infections. Cambridge University, 1990:402-442.
16. Yang Z-P, Kuo C-C, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Inf Dis 1995; 171:736-738.
17. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunohistochemical stain. Arterioscler Thromb 1993; 13(10):1501-1503.
18. Puolakkainen M, Kuo C-C, Shor A, Wang S-P, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 1993; 31(8):2212-2214.
19. Knoebel E, Vijayagopal P, Figueroa JE, Martin DH. In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Inf Immobil 1997; 65(2):503-506.
20. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. Inf Immunol 1998; 177(3):725-729.
21. Nieto FJ, Folsom AR, Sorlie PD, Grayston JT, Wang SP, Chambless LE. Chlamydia pneumoniae infection and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol 1999; 150(2):149-156.